The Outcomes of Total Hip Replacement in Patients with Parkinson's Disease: Comparison of the Elective and Hip Fracture Groups

Parkinson's Disease
Pavel ŠponerDaniel Waciakowski

Abstract

The aim of the study was to compare the clinical outcomes following elective and traumatic total hip arthroplasty in Parkinson's disease patients. Ten patients with osteoarthritis comprise the elective group (mean age at operation 74 years; mean follow-up 82 months). Thirteen patients with femoral fracture comprise the hip fracture group (mean age 76 years; mean follow-up 54 months). All patients were followed up at 6 and 36 months postoperatively and at the time of the latest follow-up. Despite the significant improvement in Merle d'Aubigné-Postel and pain scores, disability related to Parkinson's disease increased during the follow-up. Whereas more than 1/3 of hip fracture patients and all elective patients walked independently at 36 months after total hip arthroplasty, 43% of living patients from both groups were able to walk independently at the time of the latest follow-up. The medical complications were seen mainly in patients with hip fracture. Excellent pain relief with preserved walking ability without support of another person and acceptable complication profile was observed in Parkinson's disease patients at 36 months after elective total hip arthroplasty. This procedure may be indicated in Parkinson's disease patien...Continue Reading

References

May 1, 1967·Neurology·M M Hoehn, M D Yahr
Feb 1, 1983·The Journal of Trauma·I EventovR Salama
Jun 25, 2002·International Orthopaedics·Martin WeberW Scott Harmsen
Sep 6, 2007·The Journal of Bone and Joint Surgery. British Volume·B M WroblewskiP A Fleming
Jun 7, 2008·The Journal of Arthroplasty·Hiromasa TaninoScott A Banks
Jan 13, 2009·The Journal of the American Academy of Orthopaedic Surgeons·Lee M Zuckerman
Mar 5, 2009·The Journal of Bone and Joint Surgery. British Volume·R S KotwalS A Jones
Oct 2, 2009·The Journal of Bone and Joint Surgery. British Volume·J M QueallyK J Mulhall
Oct 15, 2009·JAMA : the Journal of the American Medical Association·Carmen A BrauerAllison B Rosen
Oct 1, 2010·Neurourology and Urodynamics·Aubrey ManackJudith K Jones
Jan 11, 2011·Journal of Strength and Conditioning Research·Ann M SwankRobert V Topp
May 10, 2011·International Urology and Nephrology·Lehana YeoJunaid Masood
Feb 8, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Richard W WalkerWilliam K Gray
Mar 28, 2013·Parkinson's Disease·Natalie E AllenColleen G Canning
Sep 1, 2010·Geriatric Orthopaedic Surgery & Rehabilitation·Scott SchnellStephen L Kates
Jul 12, 2013·Progress in Palliative Care·Lynn LethbridgeGeorge Turnbull
Jul 1, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Tamara PringsheimThomas D L Steeves
Oct 22, 2014·Journal of Orthopaedics and Traumatology : Official Journal of the Italian Society of Orthopaedics and Traumatology·Riazuddin MohammedMurray Wallace
Jul 2, 2015·British Medical Bulletin·Rebecca J CritchleyDavid J Deehan
Sep 16, 2015·JAMA : the Journal of the American Medical Association·Yannick Le ManachP J Devereaux
Jun 23, 2016·Acta Orthopaedica·Tonny J Pedersen, Jens M Lauritsen
Aug 3, 2016·The Journal of Arthroplasty·Matthew J GrossoWilliam B Macaulay
Nov 17, 2016·Geriatric Orthopaedic Surgery & Rehabilitation·Mustafa YassinDror Robinson

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy
hip
total hip arthroplasty
total hip arthroplasties

Software Mentioned

NCSS
MS Excel

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.